Bosh sahifaESPR • NASDAQ
add
Esperion Therapeutics Inc
2,44 $
Seans yopilganidan keyin:(3,22%)+0,079
2,52 $
Yopilgan:13-mar, 20:00:00 (GMT-4) · USD · NASDAQ · Ogohlantirish
Yopilish kursi
2,47 $
Kunlik diapazon
2,38 $ - 2,59 $
Yillik diapazon
0,69 $ - 4,18 $
Bozor kapitalizatsiyasi
626,62 mln USD
Oʻrtacha hajm
4,39 mln
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 168,45 mln | 143,73% |
Joriy xarajat | 41,43 mln | 12,21% |
Sof foyda | 61,83 mln | 390,04% |
Sof foyda marjasi | 36,71 | 219,00% |
Har bir ulushga tushum | 0,22 | 319,12% |
EBITDA | 85,26 mln | 2 040,79% |
Amaldagi soliq stavkasi | 2,89% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 167,85 mln | 15,95% |
Jami aktivlari | 465,89 mln | 35,50% |
Jami passivlari | 767,85 mln | 4,82% |
Umumiy kapital | -301,96 mln | — |
Tarqatilgan aksiyalar | 256,81 mln | — |
Narxi/balansdagi bahosi | -2,01 | — |
Aktivlardan daromad | 51,35% | — |
Kapitaldan daromad | 107,71% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 61,83 mln | 390,04% |
Operatsiyalardan naqd pul | 45,24 mln | 229,44% |
Sarmoyadan naqd pul | — | — |
Moliyadan naqd pul | 30,16 mln | -13,81% |
Naqd pulning sof oʻzgarishi | 75,40 mln | 171 275,00% |
Boʻsh pul | 958,12 ming | 102,05% |
Haqida
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan. Wikipedia
Tashkil etilgan
may 1998
Sayt
Xodimlar soni
294
